A carregar...

Cardioprotective interventions for cancer patients receiving anthracyclines

BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: van Dalen, Elvira C, Caron, Huib N, Dickinson, Heather O, Kremer, Leontien CM
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2011
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/
https://ncbi.nlm.nih.gov/pubmed/21678342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!